Good article in the Journal of the Neurological Sciences June 16, 2020 In this systematic review, we will discuss the evidence on the occurrence of central nervous system (CNS) involvement and […]
CMS Finalizes Medicare Coverage Policy for Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease Decision Follows Robust Stakeholder Input and Creates Pathway for Enhanced Access and Coverage […]
FDA Authorizes Second COVID Booster
FDA currently reviewing the ability of VESTEX® to reduce COVID-19. While the FDA has not yet reviewed the ability of products protected by VESTEX® to reduce COVID-19, preliminary research has documented results […]
Memo # QSO-22-07-ALL Posting Date 2021-12-28 Fiscal Year 2022 Summary CMS is committed to ensuring America’s healthcare facilities respond effectively in an evidence-based way to the Coronavirus Disease 2019 (COVID-19) […]
As of December 23, 2021 Due to concerns about increased transmissibility of the SARS-CoV-2 Omicron variant, this guidance is being updated to enhance protection for healthcare personnel (HCP), patients, and visitors, […]
Middle East Respiratory Syndrome Coronavirus, MERS-CoV, MERS cases in the United States, MERS in Orlando, MERS in Indiana, Signs and symptoms of MERS, How MERS is transmitted, what do I do if I’m think I have MERS,